Sandeep Laumas Biography and Net Worth

Chief Financial Officer & Chief Business Officer of Instil Bio


Dr. Laumas has served as the Chief Financial Officer and Chief Business Officer of Instil Bio since February, 2021 and June 2020, respectively. He began his career at Goldman Sachs & Co. in 1996 in the healthcare investment banking division before transitioning to the healthcare equity research division. He was an analyst at Balyasny Asset Management from 2001-03 and then a Managing Director of North Sound Capital from 2003-07, where he was responsible for the global healthcare investment portfolio. He founded and managed Bearing Circle Capital, an investment partnership, since 2008. Dr. Laumas has served as a member of the board of directors of Bioxcel Therapeutics Inc. since 2017 and a board member of Unicycive Therapeutics Inc. since 2018. He previously served as a board member of 9 Meters Biopharma, Inc. from 2020-21, its Executive Chairman from 2014-20, including its Chief Executive Officer from 2019-20. Dr. Laumas received his A.B. (Chemistry) from Cornell University in 1990, his M.D. from Albany Medical College in 1995, with a research year at the Dana-Farber Cancer Institute and completed his medical internship at the Yale University School of Medicine in 1996.

How do I contact Sandeep Laumas?

The corporate mailing address for Dr. Laumas and other Instil Bio executives is CONTINENTAL BUILDING 25 CHURCH STREET, HAMILTON D0, HM1Z. Instil Bio can also be reached via phone at 972-499-3350 and via email at [email protected]. Learn More on Sandeep Laumas' contact information.

Has Sandeep Laumas been buying or selling shares of Instil Bio?

Sandeep Laumas has not been actively trading shares of Instil Bio during the last quarter. Most recently, Sandeep Laumas sold 30,000 shares of the business's stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $23.39, for a transaction totalling $701,700.00. Learn More on Sandeep Laumas' trading history.

Who are Instil Bio's active insiders?

Instil Bio's insider roster includes Bronson Crouch (Chairman & CEO ), Sandeep Laumas (CFO & Chief Bus. Officer ), and Sandeep Laumas (Chief Financial Officer & Chief Business Officer). Learn More on Instil Bio's active insiders.

Sandeep Laumas Insider Trading History at Instil Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2025Sell30,000$23.39$701,700.00View SEC Filing Icon  
See Full Table

Sandeep Laumas Buying and Selling Activity at Instil Bio

This chart shows Sandeep Laumas's buying and selling at Instil Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Instil Bio Company Overview

Instil Bio logo
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $7.07
Low: $7.13
High: $7.24

50 Day Range

MA: $7.39
Low: $7.07
High: $7.86

2 Week Range

Now: $7.07
Low: $5.67
High: $21.98

Volume

1,492 shs

Average Volume

51,838 shs

Market Capitalization

$47.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91